The synthetic biology market is undergoing a profound transformation, driven by the advent of innovative approaches like cell-free technology. Once seen as a niche segment within the broader biotech landscape, cell-free systems are now emerging as a game-changer, offering unprecedented flexibility and efficiency in biomanufacturing. The cell-free technology and cell-free system markets are rapidly expanding,…
IDST Monthly Access Membership Required
You must be a IDST Monthly Access member to access this content.
IDST Pro Access Required
This analysis is part of IDST premium intelligence.
Subscribe to Continue ReadingAlready a member? Log in